We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $5.49B
1-Year Est. Return 46.89%
This Fund
S&P 500
This Quarter Est. Return
+17.05%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$5.9B
AUM Growth
+$1.54B
Cap. Flow
+$778M
Cap. Flow %
13.18%
Top 10 Hldgs %
56.62%
Holding
76
New
20
Increased
28
Reduced
15
Closed
13
Avg Time Held Equity + Options
7.6 quarters
Top 10 Avg Time Held Equity + Options
7.1 quarters
Top 20 Avg Time Held Equity + Options
6.8 quarters
Avg Time Held Equity only
7.6 quarters
Top 10 Avg Time Held Equity only
7.1 quarters
Top 20 Avg Time Held Equity only
6.8 quarters

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$135M
2
META icon
Meta Platforms (Facebook)
META
+$130M
3
MCK icon
McKesson
MCK
+$108M
4
COR icon
Cencora
COR
+$102M
5
BFLY icon
Butterfly Network
BFLY
+$94.5M

Top Sells

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$229M
2
LYFT icon
Lyft
LYFT
+$89.2M
3
LH icon
Labcorp
LH
+$77.5M
4
CAR icon
Avis
CAR
+$63.2M
5
EXPE icon
Expedia Group
EXPE
+$56.8M

Sector Composition

Rank Sector Weight
1 Healthcare 67.77%
2 Technology 12.16%
3 Communication Services 5.14%
4 Materials 4.77%
5 Industrials 4.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
THC icon
1
Tenet Healthcare
THC
$21.5B
$714M 12.09%
13,725,320
-4,533,490
-25% -$229M
2013 Q2
31 quarters
BHC icon
2
Bausch Health
BHC
$2.2B
$496M 8.4%
15,613,090
-820,929
-5% -$24.1M
2018 Q3
10 quarters
CI icon
3
Cigna
CI
$74.7B
$449M 7.61%
1,858,867
+603,846
+48% +$135M
2013 Q2
31 quarters
MCK icon
4
McKesson
MCK
$112B
$343M 5.82%
1,760,705
+593,016
+51% +$108M
2016 Q4
17 quarters
DXC icon
5
DXC Technology
DXC
$2.04B
$331M 5.6%
10,582,485
+433,426
+4% +$11.9M
2017 Q2
15 quarters
TAK icon
6
Takeda Pharmaceutical
TAK
$59.2B
$294M 4.98%
16,104,222
+843,710
+6% +$15.2M
2019 Q1
8 quarters
COR icon
7
Cencora
COR
$63B
$214M 3.63%
1,814,078
+938,636
+107% +$102M
2018 Q1
12 quarters
HCA icon
8
HCA Healthcare
HCA
$99.8B
$202M 3.42%
1,070,460
-229,721
-18% -$40.5M
2013 Q2
31 quarters
UHS icon
9
Universal Health Services
UHS
$10.6B
$155M 2.62%
1,159,140
+534,988
+86% +$70.9M
2016 Q3
18 quarters
META icon
10
Meta Platforms (Facebook)
META
$1.94T
$145M 2.45%
491,855
+482,269
+5,031% +$130M
2020 Q4
1 quarter
GOOGL icon
11
Alphabet (Google) Class A
GOOGL
$4.33T
$136M 2.3%
1,318,680
+750,500
+132% +$74.1M
2015 Q4
21 quarters
NUAN
12
DELISTED
Nuance Communications, Inc.
NUAN
$135M 2.28%
3,090,291
+851,924
+38% +$39.2M
2018 Q3
10 quarters
BSX icon
13
Boston Scientific
BSX
$62.8B
$124M 2.09%
3,197,966
+495,085
+18% +$18.7M
2020 Q1
4 quarters
BAX icon
14
Baxter International
BAX
$12.9B
$116M 1.97%
1,377,998
+819,166
+147% +$65M
2020 Q1
4 quarters
BKD icon
15
Brookdale Senior Living
BKD
$2.42B
$109M 1.85%
18,048,945
+43,035
+0.2% +$232K
2014 Q2
27 quarters
FISV icon
16
Fiserv Inc
FISV
$24.8B
$104M 1.77%
877,447
+393,721
+81% +$45.2M
2019 Q3
6 quarters
FMC icon
17
FMC
FMC
$1.29B
$95.1M 1.61%
859,688
+147,892
+21% +$16.4M
2015 Q1
24 quarters
ELV icon
18
Elevance Health
ELV
$92.2B
$94.6M 1.6%
263,633
+79,172
+43% +$25.5M
2020 Q4
1 quarter
HUM icon
19
Humana
HUM
$50.5B
$81.3M 1.38%
193,938
+34,458
+22% +$13.8M
2018 Q4
9 quarters
BFLY icon
20
Butterfly Network
BFLY
$2.16B
$80.4M 1.36%
+4,774,846
New +$94.5M
2021 Q1
0 quarters
MYGN icon
21
Myriad Genetics
MYGN
$390M
$78.2M 1.33%
2,569,433
-1,113,258
-30% -$31.6M
2019 Q3
6 quarters
CCEP icon
22
Coca-Cola Europacific Partners
CCEP
$46.3B
$71.3M 1.21%
+1,367,451
New +$69.5M
2021 Q1
0 quarters
MOH icon
23
Molina Healthcare
MOH
$10.9B
$71.1M 1.2%
304,023
+119,303
+65% +$26.6M
2020 Q1
4 quarters
WBA icon
24
DELISTED
Walgreens Boots Alliance
WBA
$70.8M 1.2%
+1,289,830
New +$63.7M
2021 Q1
0 quarters
UNP icon
25
Union Pacific
UNP
$168B
$70.1M 1.19%
318,106
+254,375
+399% +$53.4M
2020 Q4
1 quarter
1
2 3 4

Similar funds

GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Glenview Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Glenview Capital Management held 76 positions worth $5.9B, up 35% from $4.36B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Glenview Capital Management deployed $778M of net new capital in Q1 2021, opening 20 new positions and adding to 28 existing holdings. Its largest new stake was Butterfly Network: 4,774,846 shares worth $80.4M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, down from 70% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Tenet Healthcare, an estimated $229M trimmed.

  • Glenview Capital Management's largest Q1 2021 buy was Butterfly Network: 4,774,846 shares worth $80.4M.
  • Glenview Capital Management added most to Cigna in Q1 2021, an estimated $135M increase.
  • Glenview Capital Management's biggest Q1 2021 reduction was Tenet Healthcare, cutting an estimated $229M.
  • Glenview Capital Management fully exited Expedia Group in Q1 2021, selling an estimated $56.8M.
  • Glenview Capital Management's ten largest holdings make up 57% of its $5.9B portfolio in Q1 2021.
  • Glenview Capital Management opened 20 new positions and closed 13 in Q1 2021.
  • Glenview Capital Management's portfolio value rose 35% quarter-over-quarter to $5.9B.

Based on Glenview Capital Management's 13F filing for Q1 2021, filed 17 May 2021.